Clinical trial
Gene Therapy for Chronic Granulomatous Diseases - Long-term Follow-up
NCT00001476 · National Institute of Allergy and Infectious Diseases (NIAID), NIH · Completed
Key facts
| NCT number | NCT00001476 |
|---|---|
| Title | Gene Therapy for Chronic Granulomatous Diseases - Long-term Follow-up |
| Official title | Gene Therapy Approach for Chronic Granulomatous Disease |
| Lead sponsor | National Institute of Allergy and Infectious Diseases (NIAID), NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Chronic Granulomatous Disease, Communicable Disease |
| Intervention type | Device, Drug |
| Interventions | Gene Therapy Method for CGD, Isolex 300i Magnetic Cell Selector |
| Enrollment | 14 |
| Start date | Jun 1, 1995 |
| Primary completion | Dec 13, 2010 |
| Completion | Dec 13, 2010 |
| First posted | Nov 4, 1999 |
| Last update posted | Jul 2, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: